SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-021496
Filing Date
2023-04-28
Accepted
2023-04-28 16:04:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20007645x3_defa14a.htm DEFA14A 9744
2 ny20007645x3_nc01.jpg GRAPHIC 1248782
3 ny20007645x3_nc02.jpg GRAPHIC 1237448
  Complete submission text file 0001140361-23-021496.txt   3430922
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40431 | Film No.: 23865804
SIC: 2834 Pharmaceutical Preparations